Literature DB >> 3345719

Stimulation of in vitro triglyceride synthesis in the rat hepatocyte by growth hormone treatment in vivo.

M B Elam1, C P Simkevich, S S Solomon, H G Wilcox, M Heimberg.   

Abstract

Hepatic fatty acid metabolism in the rat is sexually differentiated. Rates of esterification by the liver of fatty acid into triglyceride and other esterification products (phospholipid, diglyceride, cholesteryl esters) are higher in the female than in the male. There is evidence to suggest that GH feminizes other hepatic systems that exhibit sexual dimorphism, including hepatic steroid metabolism, PRL receptors, and estrogen binding. To investigate the role of GH in maintenance of the high rates of fatty acid esterification observed in the female, we assessed rates of [1-14C]oleic acid utilization by hepatocytes prepared from hypophysectomized (hypox) cortisol/T3-replaced female rats with an without continuous in vivo infusion of human (h) GH (5 micrograms/h). In addition, we assessed the effect of in vivo hGH treatment (5 micrograms/h) on [1-14C]oleic acid utilization in the normal male rat. Hypophysectomy was accompanied by a reduction in incorporation of [1-14C]oleic acid into products of esterification (triglyceride, phospholipid, diglyceride) and oxidation (CO2, ketone bodies). Continuous infusion of hGH (5 micrograms/h; 14 days) restored rates of fatty acid esterification in the hypox-cortisol/T3-replaced female rat, with the exception of cholesteryl esters. hGH infusion partially restored rates of fatty acid oxidation in the hypox cortisol/T3-replaced female rat. Treatment of the adult male rat with continuous infusion of hGH (5 micrograms/h; 7 days) resulted in increased rates of incorporation of [1-14C] oleic acid into triglyceride. In contrast, incorporation of oleic acid into phospholipid, diglyceride, and cholesteryl esters was unaltered. These results suggest that GH may be an important regulator of hepatic fatty acid metabolism.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3345719     DOI: 10.1210/endo-122-4-1397

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  6 in total

1.  Insulin promotes the biosynthesis and secretion of apolipoprotein B-48 by altering apolipoprotein B mRNA editing.

Authors:  F E Thorngate; R Raghow; H G Wilcox; C S Werner; M Heimberg; M B Elam
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

2.  Loss of resistance to dietary cholesterol in the rat after hypophysectomy: importance of the presence of growth hormone for hepatic low density lipoprotein-receptor expression.

Authors:  M Rudling; B Angelin
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-01       Impact factor: 11.205

3.  Regulation of rat hepatic low density lipoprotein receptors. In vivo stimulation by growth hormone is not mediated by insulin-like growth factor I.

Authors:  M Rudling; H Olivecrona; G Eggertsen; B Angelin
Journal:  J Clin Invest       Date:  1996-01-15       Impact factor: 14.808

4.  Modulation of very low density lipoprotein production and clearance contributes to age- and gender- dependent hyperlipoproteinemia in apolipoprotein E3-Leiden transgenic mice.

Authors:  B J van Vlijmen; H B van 't Hof; M J Mol; H van der Boom; A van der Zee; R R Frants; M H Hofker; L M Havekes
Journal:  J Clin Invest       Date:  1996-03-01       Impact factor: 14.808

5.  Cocoa butter and safflower oil elicit different effects on hepatic gene expression and lipid metabolism in rats.

Authors:  Carolina Gustavsson; Paolo Parini; Jovanca Ostojic; Louisa Cheung; Jin Hu; Fahad Zadjali; Faheem Tahir; Kerstin Brismar; Gunnar Norstedt; Petra Tollet-Egnell
Journal:  Lipids       Date:  2009-10-06       Impact factor: 1.880

6.  Sex-different hepaticglycogen content and glucose output in rats.

Authors:  Carolina Gustavsson; Kamal Yassin; Erik Wahlström; Louisa Cheung; Johan Lindberg; Kerstin Brismar; Claes-Göran Ostenson; Gunnar Norstedt; Petra Tollet-Egnell
Journal:  BMC Biochem       Date:  2010-09-23       Impact factor: 4.059

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.